(“Mustang”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Research shows that this approach results in long lasting clinical remission in cancer patients and protective immunity against infections. They employ messenger RNA to unleash and boost a patient’s immune response against a tumor or infectious agent. Stemirna’s current pipeline include personalized cancer vaccines and prophylactic vaccines for infectious diseases.ĮTheRNA Immunotherapies Belgium Private eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases. Taking advantage of its two innovative mRNA platforms – a comprehensive mRNA delivery platform and an IVT-mRNA synthesis platform – Stemirna Therapeutics turns the patient’s body into a drug factory that produces medicines for itself. Stemirna Therapeutics China Private As the first biotech company in China to focus on mRNA therapeutics, Stemirna strives to deliver novel cure for patients in the world. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. In addition, Heat is also developing a pipeline of proprietary immunomodulatory antibodies, including PTX-35 which is enrolling in a Phase 1 trial.ĬureVac Germany Private CureVac is a leading clinical stage biotechnology company in the field of messenger RNA (mRNA) technology with 20 years of expertise in developing and optimizing this versatile molecule for medical purposes. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, HS-130 in Phase 1, and a COVID-19 vaccine program in preclinical development. The company's gp96 platform is designed to activate immune responses against cancer or pathogenic antigens. Heat Biologics USA Listed Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system.
#Venture forthe medisked archive
Community submitted dataĪssociated sectors: Life Sciences Biologics Healthtech SARS-CoV-2 Vaccine Cancer Melanoma Immunotherapy Diagnostics DNA RNA Peptide Therapies Vaccines Biotech Website archive shows the site was first archived on 2016. We work directly with corporations and also with service providers (such as open innovation agencies, outsourced R&D consultants, and traditional crowd-sourcing companies) to provide them with our intelligent company discovery capabilities. By structuring and analysing this information we are able to accurately match our clients needs with the start-ups, SMEs and other innovators that have the skills our clients need.
We discover innovative companies from across the globe using our Company Discovery Engine, which trawls the web to harvest and aggregate company information at a scale, speed and efficiency that hasn’t previously been possible.
VentureRadar helps organisations innovate and generate new growth by connecting them to the emerging technologies and expertise that can solve their challenges.
0 kommentar(er)
